NEWS & EVENTS

Latest news and upcoming events

Memo Therapeutics increases Series C financing to CHF 45 million
07 May 2024

Memo Therapeutics increases Series C financing to CHF 45 million

Upcoming events
  • Bio€quity Europe
    14 - 16 May 2024,
    San Sebastián

    download
  • AseBio Investor Day 2024
    15 May 2024,
    San Sebastián

    download
  • ESMO Congress 2024
    13 - 19 September 2024,
    Barcelona

    download

Ysios Capital Partners leads €5million Series A Financing of Sabirmedical

BARCELONA 23th September 2010. Ysios Capital Partners today announces that it has led the Series A investment of Sabirmedical, company based in the Barcelona Science Park developing medical devices and sensor technologies.

Ysios Capital Partners participates in Cardoz’ €10million Series A financing round.

Cardoz AB, a clinical stage company, today announced that it has closed a series A financing round of SEK 100 million (€ 10 million) with an international syndicate of venture capital investors.

Ysios Capital Partners participates in Cardoz’ €10million Series A financing round.

Cardoz AB, a clinical stage company, today announced that it has closed a series A financing round of SEK 100 million (€ 10 million) with an international syndicate of venture capital investors.

Ysios Capital Partners participates in Biovex’s $70million final closing

Woburn, MA, November 10, 2009 ‐‐ BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that it has concluded a $70 million private financing, raising $30 million in addition to the $40 million announced in March.

Ysios Capital Partners participates in Biovex’s $70million final closing

Woburn, MA, November 10, 2009 ‐‐ BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that it has concluded a $70 million private financing, raising $30 million in addition to the $40 million announced in March.

Laia Crespo joins Ysios Capital Partners as Investment Manager<

Laia Crespo joins Ysios Capital Partners as Investment Manager

Main responsibilities of Laia Crespo will include the identification and assessment of investment and disinvestment opportunities from the scientific and business perspectives

Ysios Capital Partners participates in the $36million . €25million Series B Financing of Endosense<

Ysios Capital Partners participates in the $36million . €25million Series B Financing of Endosense

Barcelona – September 1, 2009 – Endosense, a medical technology company focused on improving efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced that it has received USD 36 million in Series B financing.

Ysios Capital Partners participates in the $36million . €25million Series B Financing of Endosense

Barcelona – September 1, 2009 – Endosense, a medical technology company focused on improving efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced that it has received USD 36 million in Series B financing.

Ysios Capital Partners announces the first closing of the largest Spanish biotech fund at €67million<

Ysios Capital Partners announces the first closing of the largest Spanish biotech fund at €67million

The fund will be invested in 10 to 12 biotechnology companies in the field of human health.

Raúl Martín-Ruiz joins Ysios Capital Partners as Investment Manager<

Raúl Martín-Ruiz joins Ysios Capital Partners as Investment Manager

Main responsibilities of Martín-Ruiz will be to analyze and evaluate the feasibility of the target companies of the fund from a scientific and business point of view.

Newsletter

subscribe

Subscribe to our weekly newsletter for the latest
updates on life sciences investments.

Bitplex 360 Кракен даркнет кракен даркнет Blacksprut Blacksprut Кракен ссылка кракен ссылка